pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
CRISPR/Cas9 · news · pharmadog
← back to CRISPR/Cas9
News · CRISPR/Cas9
99
stories
Apr 27, 26
STAT+: Erasca touts strong, though preliminary, results in trial of pancreatic and lung cancer therapy
stat
Apr 27, 26
Q&A: Intellia CEO talks first Phase 3 CRISPR readout and what’s next
endpoints
Apr 27, 26
STAT+: Astellas retries XLMTM gene therapy after deaths
stat
Apr 27, 26
STAT+: Pharmalittle: We’re reading about a Lilly deal, an Intellia CRISPR rare-disease treatment, and more
stat
Apr 27, 26
Intellia CRISPR drug succeeds in late-stage study against rare swelling disorder
biopharma dive
Apr 27, 26
Intellia's in vivo CRISPR therapy first to succeed in Phase 3
endpoints
Apr 27, 26
STAT+: Intellia says CRISPR-based treatment for rare disease reduced swelling attacks in pivotal trial
stat
Apr 27, 26
STAT+: Zap in a cap: How one neurotech startup is using a hat to treat depression
stat
Apr 23, 26
Endpoints wins Neal Awards for Trump and gene editing coverage, JPM event
endpoints
← prev
page 4 of 4
next →
